logo-loader
MMJ Group Holdings Ltd

MMJ Phytotech CEO will outline medicinal cannabis strategy at CEO Session

The company has this week entered into a cannabis concentrate program agreement with a Canadian company.

Cannabis and medicinal cannabis products
Jason Conroy will present at the CEO Session in Sydney on October 22

MMJ PhytoTech Ltd (ASX:MMJ) has an active strategy in the medicinal cannabis sector which chief executive officer Jason Conroy will outline at the Proactive CEO Sessions in Sydney on Monday, October 22.

The company recently confirmed the disposal of subsidiary PhytoTech Therapeutics Ltd (PTL) to Harvest One Cannabis Inc (TSX-V:HVT), which led to suspension from the ASX.

READ: MMJ PhytoTech applies for ASX re-quotation, Canadian cannabis investment enters distribution agreement

A re-quotation application has been made, which also incorporates a change of name to MMJ Group Holdings Limited.

This week the company has confirmed that its investment MediPharm Labs Inc (TSX-V:LABS) entered into a cannabis concentrate program agreement with Emerald Health Therapeutics Inc (TSX-V:EMH).

MMJ’s investment in MediPharm amounts to C$5 million, comprising 5.88 million shares at 85 Canadian cents per share and 2.94 million warrants exercisable at C$1.20 a share by October 2020.

This agreement enables Emerald to provide pharmaceutical-grade cannabis concentrate products produced by MediPharm to its large base of registered patients as well as premium concentrates for adult-use recreational consumers.

MediPharm is focused on downstream secondary extraction methodology, distillation and cannabinoid isolation and purification.

The company operates of one the largest cannabis concentrate manufacturing facilities in Canada and is built current good manufacturing practices and ISO standards.

Divestment notice lodged

Today MMJ announced that it has lodged a notice with the TSX Venture Exchange stating its intention to divest up to 5 million of its 53.333 million shares held in Harvest One.

The notice is a Canadian regulatory requirement as MMJ’s shareholding of approximately 30% in Harvest One is more than the 20% ownership threshold.

On completion of the sale of PTL, MMJ’s shareholding in Harvest One will increase by the equivalent of C$6.86 million divided by the 10-day volume weighted average price of Harvest One shares preceding settlement of that sale.

Conroy said, “After being fully-invested since the end of July, and with a significant shareholding in Harvest One that will increase on completion of the PTL sale, it is prudent to be ready and able to trim our ownership stake so we can participate in other cannabis sector investment opportunities as they arise.”

Register for the CEO Session today to find out more.

Sydney details, Monday, October 22, 2018

Also featuring will be Yandal Resources Limited (ASX:YRL), High Peak Royalties Ltd (ASX:HPR), Minotaur Exploration Ltd (ASX:MEP) and The Hydroponics Company Ltd (ASX:THC).

Quick facts: MMJ Group Holdings Ltd

Price: $0.26

Market: ASX
Market Cap: $58.69 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MMJ Group Holdings Ltd named herein, including the promotion by the Company of MMJ Group Holdings Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

MMJ Group focuses on strategic vision to be leading cannabis investment company

MMJ Group Holdings Ltd (ASX: MMJ) non-executive director Mike Curtis updates Proactive Investors about its strategic partnership with MMJ operating company Embark Ventures (EBV). The two companies have combined to create the highest quality investments, earnings and share price return for...

on 17/7/19

3 min read